Eiger BioPharmaceuticals, Inc. Insider Trading for March 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eiger BioPharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eiger BioPharmaceuticals, Inc. for March 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Apelian David | COO and Ex. Medical ... | Option Exercise | A | 14.31 | 110,500 | 1,581,255 | 110,500 | |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 14.31 | 50,000 | 715,500 | 50,000 | |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 7.95 | 1,500 | 11,921 | 12,921 | 11.4 K to 12.9 K (+13.13 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 7.95 | 1,500 | 11,921 | 11,421 | 9.9 K to 11.4 K (+15.12 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 8.03 | 1,500 | 12,049 | 9,921 | 8.4 K to 9.9 K (+17.81 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 9.90 | 1,500 | 14,854 | 8,421 | 6.9 K to 8.4 K (+21.67 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 8.20 | 1,301 | 10,671 | 6,921 | 5.6 K to 6.9 K (+23.15 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Option Exercise | A | 14.31 | 200,000 | 2,862,000 | 200,000 | |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 7.95 | 1,500 | 11,921 | 66,003 | 64.5 K to 66 K (+2.33 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 7.95 | 1,500 | 11,921 | 64,503 | 63 K to 64.5 K (+2.38 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 8.03 | 1,500 | 12,049 | 63,003 | 61.5 K to 63 K (+2.44 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 9.90 | 1,500 | 14,854 | 61,503 | 60 K to 61.5 K (+2.50 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 8.20 | 1,325 | 10,868 | 60,003 | 58.7 K to 60 K (+2.26 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Murray Christine | Director | Option Exercise | A | 13.41 | 10,000 | 134,100 | 10,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Director | Option Exercise | A | 13.41 | 10,000 | 134,100 | 10,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Director | Option Exercise | A | 13.41 | 10,000 | 134,100 | 10,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 13.41 | 20,000 | 268,200 | 20,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 13.41 | 20,000 | 268,200 | 20,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Glenn Jeffrey S | Director | Option Exercise | A | 14.31 | 10,000 | 143,100 | 10,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Glenn Jeffrey S | Director | Option Exercise | A | 14.31 | 10,000 | 143,100 | 10,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 14.31 | 10,000 | 143,100 | 10,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 14.31 | 10,000 | 143,100 | 10,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Patton Stephana Eilene | See Remarks | Option Exercise | A | 14.31 | 90,000 | 1,287,900 | 90,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Patton Stephana Eilene | See Remarks | Option Exercise | A | 14.31 | 90,000 | 1,287,900 | 90,000 |